Revised international prognostic scoring system for myelodysplastic syndromes

PL Greenberg, H Tuechler, J Schanz… - Blood, The Journal …, 2012 - ashpublications.org
Abstract The International Prognostic Scoring Sytem (IPSS) is an important standard for
ssessing prognosis of primary untreated adult patients with myelodysplastic syndromes …

Prognostic scoring systems in MDS

U Germing, A Kündgen - Leukemia research, 2012 - Elsevier
Prognostic scoring systems in myelodysplastic syndromes are useful tools in order to get in
idea on the expected course of the disease and offer patients a risk adapted treatment …

Analyzing transformation of myelodysplastic syndrome to secondary acute myeloid leukemia using a large patient database

O Shukron, V Vainstein, A Kündgen… - American journal of …, 2012 - Wiley Online Library
One‐third of patients with myelodysplastic syndrome (MDS) progress to secondary acute
myeloid leukemia (sAML), with its concomitant poor prognosis. Recently, multiple mutations …

Angiogenesis and survival in patients with myelodysplastic syndrome

A Savic, V Cemerikic-Martinovic, S Dovat… - Pathology & Oncology …, 2012 - Springer
Angiogenesis has been implicated in the pathogenesis and prognosis of myelodysplastic
syndrome (MDS). In this study, we investigated the relationship between microvessel density …

Time changes in predictive power of established and recently proposed clinical, cytogenetical and comorbidity scores for Myelodysplastic Syndromes

M Pfeilstöcker, H Tüchler, A Schönmetzler… - Leukemia research, 2012 - Elsevier
BACKGROUND: Recent improvements in the treatment of Myelodysplastic Syndromes have
fostered further interest in the development of prognostic scores. Prognostic indices such as …

148 例骨髓增生异常综合征患者实验室指标与预后相关性分析

李雯雯, 李燕, 王晓敏 - 临床血液学杂志, 2012 - whuhzzs.com
目的: 研究骨髓增生异常综合征(MDS) 患者平均红细胞体积(MCV), 血清乳酸脱氢酶(LDH), β 2-
微球蛋白(β 2-MG), 铁蛋白(SF), VitB 12 等实验室指标与疾病预后的相关性. 方法: 分析148 …

Diagnosis and therapy of myelodysplastic syndromes in Germany: a retrospective multicenter analysis

N Gattermann, A Kündgen, L Kellermann… - Oncology Research …, 2012 - karger.com
Background: Myelodysplastic syndromes (MDS) are a heterogenous group of clonal
hematopoietic stem cell disorders. Patients and Methods: In order to assess current …

Терапия и профилактика анемии и перегрузки железом у больных миелодиспластическим синдромом

НА Романенко - Medline. ru. Российский биомедицинский журнал, 2012 - elibrary.ru
В лекции представлена ВОЗ классификация 2008 г. миелодиспластического синдрома,
прогностические шкалы IPSS и WPSS, рассмотрены механизмы развития анемии и …

[PDF][PDF] Cytogenetic Evaluation in 221 Untreated Patients with Myelodysplastic Syndrome/Tedavi Almamis 221 Miyelodisplastik Sendromlu Hastada Sitogenetik …

A Deviren, IMG Msc, SY Msc… - Türkiye Klinikleri. Tip …, 2012 - academia.edu
Ob jec ti ve: Mye lodys plas tic syndro mes (MDS) are a he te ro ge ne o us gro up of ma lig
nant clonal he ma to po ie tic stem cell di sor ders cha rac te ri zed by bo ne mar row fa i lu …

[PDF][PDF] The quest for the perfect MDS scoring system

V Santini - Leukemia Research, 2012 - flore.unifi.it
The work of Pfeilstöcker et al. addresses and dissects very well the first two points, just
touching the third one. At least 20 different prognostic scoring systems have been produced …